Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.)

Plaintiff States sought damages and injunctive relief, alleging that the drug company, Bristol-Myers Squibb, Co. (BMS) wrongfully maintained a monopoly on Taxol, a drug for which the Plaintiff States alleged Defendant fraudulently filed a patent. BMS’s alleged wrongful action delayed entry into the market by generic competitors of the drug, resulting in higher prices for Taxol. In 2008, plaintiff states sued BMS for failing to report accurately to the states, pursuant to the settlemen, a patent arrangement involving the drug Plavix. The company pleaded guilty to lying to the FTC and the states recovered $1.1 million in fines.

Read More →

Maryland v. Medical Staff of Harford Memorial Hospital, 1981-2 Trade Cas. (CCH) 64,430 (Md. Ct. 1981)

State sought an injunction, alleging that Defendant, Medical Staff of Harford Memorial Hospital (Harford), agreed to refuse to deal with any radiologists who were in competition with O. G. Radiology Associates. The State further alleged that the purpose of the agreement was to prevent Harford from obtaining radiological services from radiologists not currently members of the Medical Staff and to compel Harford to accept the contractual terms demanded by O. G. Radiology Associates. As a result of the alleged agreement, radiologists were foreclosed from access to patients, and therefore excluded from the market.

Read More →

West Virginia ex rel. McGraw v. Kimberly-Clark Corporation, et al., No. 99-C-2349 (Cir. Ct. Kanawha Cty. 2000)

Suit alleged price-fixing in the commercial tissue paper market. After dismissal from federal court, state refiled in state court and parties reached a settlement.

Read More →